Thieno[3,2-b]pyridine-2-sulfonic acid [1-(1,6-diamino-isoquinolin-7-ylmethyl)-2-oxo-pyrrolidin-3-yl]-amide

ID: ALA85938

PubChem CID: 15546794

Max Phase: Preclinical

Molecular Formula: C21H20N6O3S2

Molecular Weight: 468.56

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1cc2ccnc(N)c2cc1CN1CC[C@H](NS(=O)(=O)c2cc3ncccc3s2)C1=O

Standard InChI:  InChI=1S/C21H20N6O3S2/c22-15-9-12-3-6-25-20(23)14(12)8-13(15)11-27-7-4-16(21(27)28)26-32(29,30)19-10-17-18(31-19)2-1-5-24-17/h1-3,5-6,8-10,16,26H,4,7,11,22H2,(H2,23,25)/t16-/m0/s1

Standard InChI Key:  UORSJJNIHCUTDL-INIZCTEOSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  1  0  0  0  0  0999 V2000
    3.7292   -0.7917    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.2417   -0.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2417    0.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7292   -0.7875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2292   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7292   -0.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7417   -0.8000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2292   -0.5042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7292   -0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2708   -0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2417    0.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2292   -0.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2292   -0.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2417   -0.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7833   -0.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7292   -1.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2708   -1.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7292   -1.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3417   -1.2875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9792   -1.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2292   -1.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7292   -1.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2833   -0.8000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7417    0.3625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2292    0.0750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7833    0.0708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2292   -1.6625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2833   -1.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7708   -1.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7542   -0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2542    0.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2542   -0.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  5  1  0
  5  6  1  0
  6  8  1  1
  7  2  1  0
  8  1  1  0
  9 13  1  0
 10 12  1  0
 11  3  1  0
 12  9  2  0
 13  4  1  0
 14  7  1  0
 15 10  2  0
 16  9  1  0
 17 21  1  0
 18  6  1  0
 19  1  2  0
 20  1  2  0
 21 16  2  0
 22 18  1  0
 23 15  1  0
 24 11  1  0
 25  5  2  0
 26 15  1  0
 27 16  1  0
 28 29  1  0
 29 17  2  0
 30 14  1  0
 31 24  2  0
 32 30  2  0
 14 11  2  0
  4 22  1  0
 32 31  1  0
 17 10  1  0
 23 28  2  0
M  END

Associated Targets(Human)

F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

F10 Coagulation factor X (201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.56Molecular Weight (Monoisotopic): 468.1038AlogP: 2.09#Rotatable Bonds: 5
Polar Surface Area: 144.30Molecular Species: BASEHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 8.54CX Basic pKa: 9.34CX LogP: -0.17CX LogD: -0.70
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.38Np Likeness Score: -1.00

References

1. Choi-Sledeski YM, Becker MR, Green DM, Davis R, Ewing WR, Mason HJ, Ly C, Spada A, Liang G, Cheney D, Barton J, Chu V, Brown K, Colussi D, Bentley R, Leadley R, Dunwiddie C, Pauls HW..  (1999)  Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA.,  (17): [PMID:10498204] [10.1016/s0960-894x(99)00421-7]
2. Pinto DJ, Smallheer JM, Cheney DL, Knabb RM, Wexler RR..  (2010)  Factor Xa inhibitors: next-generation antithrombotic agents.,  53  (17): [PMID:20503967] [10.1021/jm100146h]

Source